Tag: Covaxin
COVAXIN® (BBV152) booster dose study shows Promising Results
The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events.
· 6 months after receipt of...
Bharat Biotech’s COVAXIN® Authorized for Emergency Use by the World Health...
Emergency Use Listing by WHO will expedite global access and availability of COVAXIN® worldwide.The WHO’s Emergency Use Listing (EUL) for COVAXIN® facilitates countries...